Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C24H32O4 |
Molecular Weight | 384.5085 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@](OC(C)=O)(C(C)=O)[C@@]1(C)CC[C@@]3([H])[C@@]2([H])C=C(C)C4=CC(=O)CC[C@]34C
InChI
InChIKey=RQZAXGRLVPAYTJ-GQFGMJRRSA-N
InChI=1S/C24H32O4/c1-14-12-18-19(22(4)9-6-17(27)13-21(14)22)7-10-23(5)20(18)8-11-24(23,15(2)25)28-16(3)26/h12-13,18-20H,6-11H2,1-5H3/t18-,19+,20+,22-,23+,24+/m1/s1
Molecular Formula | C24H32O4 |
Molecular Weight | 384.5085 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:08:27 UTC 2023
by
admin
on
Fri Dec 15 15:08:27 UTC 2023
|
Record UNII |
TJ2M0FR8ES
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EU-Orphan Drug |
EU/3/17/1858
Created by
admin on Fri Dec 15 15:08:27 UTC 2023 , Edited by admin on Fri Dec 15 15:08:27 UTC 2023
|
||
|
NCI_THESAURUS |
C776
Created by
admin on Fri Dec 15 15:08:27 UTC 2023 , Edited by admin on Fri Dec 15 15:08:27 UTC 2023
|
||
|
FDA ORPHAN DRUG |
26187
Created by
admin on Fri Dec 15 15:08:27 UTC 2023 , Edited by admin on Fri Dec 15 15:08:27 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
595-33-5
Created by
admin on Fri Dec 15 15:08:27 UTC 2023 , Edited by admin on Fri Dec 15 15:08:27 UTC 2023
|
PRIMARY | |||
|
100000090117
Created by
admin on Fri Dec 15 15:08:27 UTC 2023 , Edited by admin on Fri Dec 15 15:08:27 UTC 2023
|
PRIMARY | |||
|
6723
Created by
admin on Fri Dec 15 15:08:27 UTC 2023 , Edited by admin on Fri Dec 15 15:08:27 UTC 2023
|
PRIMARY | |||
|
SUB03117MIG
Created by
admin on Fri Dec 15 15:08:27 UTC 2023 , Edited by admin on Fri Dec 15 15:08:27 UTC 2023
|
PRIMARY | |||
|
TJ2M0FR8ES
Created by
admin on Fri Dec 15 15:08:27 UTC 2023 , Edited by admin on Fri Dec 15 15:08:27 UTC 2023
|
PRIMARY | |||
|
1379106
Created by
admin on Fri Dec 15 15:08:27 UTC 2023 , Edited by admin on Fri Dec 15 15:08:27 UTC 2023
|
PRIMARY | |||
|
CHEMBL1201139
Created by
admin on Fri Dec 15 15:08:27 UTC 2023 , Edited by admin on Fri Dec 15 15:08:27 UTC 2023
|
PRIMARY | |||
|
1667
Created by
admin on Fri Dec 15 15:08:27 UTC 2023 , Edited by admin on Fri Dec 15 15:08:27 UTC 2023
|
PRIMARY | |||
|
209-864-5
Created by
admin on Fri Dec 15 15:08:27 UTC 2023 , Edited by admin on Fri Dec 15 15:08:27 UTC 2023
|
PRIMARY | |||
|
29451
Created by
admin on Fri Dec 15 15:08:27 UTC 2023 , Edited by admin on Fri Dec 15 15:08:27 UTC 2023
|
PRIMARY | RxNorm | ||
|
DTXSID9040683
Created by
admin on Fri Dec 15 15:08:27 UTC 2023 , Edited by admin on Fri Dec 15 15:08:27 UTC 2023
|
PRIMARY | |||
|
DB00351
Created by
admin on Fri Dec 15 15:08:27 UTC 2023 , Edited by admin on Fri Dec 15 15:08:27 UTC 2023
|
PRIMARY | |||
|
Megestrol acetate
Created by
admin on Fri Dec 15 15:08:27 UTC 2023 , Edited by admin on Fri Dec 15 15:08:27 UTC 2023
|
PRIMARY | |||
|
11683
Created by
admin on Fri Dec 15 15:08:27 UTC 2023 , Edited by admin on Fri Dec 15 15:08:27 UTC 2023
|
PRIMARY | |||
|
71423
Created by
admin on Fri Dec 15 15:08:27 UTC 2023 , Edited by admin on Fri Dec 15 15:08:27 UTC 2023
|
PRIMARY | |||
|
m7146
Created by
admin on Fri Dec 15 15:08:27 UTC 2023 , Edited by admin on Fri Dec 15 15:08:27 UTC 2023
|
PRIMARY | Merck Index | ||
|
D019290
Created by
admin on Fri Dec 15 15:08:27 UTC 2023 , Edited by admin on Fri Dec 15 15:08:27 UTC 2023
|
PRIMARY | |||
|
TJ2M0FR8ES
Created by
admin on Fri Dec 15 15:08:27 UTC 2023 , Edited by admin on Fri Dec 15 15:08:27 UTC 2023
|
PRIMARY | |||
|
C1156
Created by
admin on Fri Dec 15 15:08:27 UTC 2023 , Edited by admin on Fri Dec 15 15:08:27 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
For the calculation of contents, multiply the peak areas by 0.6
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
The following peaks are eluted at the following relative retention with reference to the peak of medroxyprogesterone acetate (retention time about 27 minutes): impurity G about 0.85. In the chromatogram obtained with solution (1):the area of any peak corresponding to impurity G, when multiplied by a correction factor of 2.6, is not greater than 2 times of the area of the principal peak obtained with solution (3) (0.2%). The test is not valid unless in the chromatogram obtained with solution (4) the resolution factor between the peaks due to impurity G and due to medroxyprogesterone acetate is at least 3.3.
|
||
|
IMPURITY -> PARENT |
For the calculation of contents, multiply the peak areas by 0.4
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
For the calculation of contents, multiply the peak areas by 0.2
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
For the calculation of contents, multiply the peak areas by 0.5
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
at 210 nm
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
For the calculation of contents, multiply the peak areas by 0.4
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |